Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®
Clinical trial NCT04905667 · COMPLETED
Trial details
- NCT number
- NCT04905667
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2020-09-08
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.